372 related articles for article (PubMed ID: 22113154)
41. Clozapine-induced systemic lupus erythematosus.
Rami AF; Barkan D; Mevorach D; Leitersdorf E; Caraco Y
Ann Pharmacother; 2006 May; 40(5):983-5. PubMed ID: 16670363
[TBL] [Abstract][Full Text] [Related]
42. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
Lau KL; Yim PH
East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
[TBL] [Abstract][Full Text] [Related]
43. A 25-Year-Old Man with Refractory Schizophrenia and Clozapine-Induced Myocarditis Diagnosed by Non-Invasive Cardiovascular Magnetic Resonance.
Brazile T; Barakat AF; Bukhari S; Schelbert EB; Soman P
Am J Case Rep; 2021 May; 22():e930103. PubMed ID: 33990535
[TBL] [Abstract][Full Text] [Related]
44. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
Karagianis JL; Phillips LC; Hogan KP; LeDrew KK
Ann Pharmacother; 1999 May; 33(5):623-30. PubMed ID: 10369628
[TBL] [Abstract][Full Text] [Related]
45. The safety of clozapine in the elderly.
Gareri P; De Fazio P; Russo E; Marigliano N; De Fazio S; De Sarro G
Expert Opin Drug Saf; 2008 Sep; 7(5):525-38. PubMed ID: 18759705
[TBL] [Abstract][Full Text] [Related]
46. Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review.
Wells AJ; Sommi RW; Crismon ML
Drug Intell Clin Pharm; 1988 Jun; 22(6):475-80. PubMed ID: 2899492
[TBL] [Abstract][Full Text] [Related]
47. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
Silva E; Higgins M; Hammer B; Stephenson P
BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
[TBL] [Abstract][Full Text] [Related]
48. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
[TBL] [Abstract][Full Text] [Related]
49. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
50. Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis: A Case Report.
Danilewitz M; Rafizadeh R; Bousman CA
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):218-220. PubMed ID: 33528148
[No Abstract] [Full Text] [Related]
51. Recognition and management of clozapine adverse effects: A systematic review and qualitative synthesis.
Gurrera RJ; Gearin PF; Love J; Li KJ; Xu A; Donaghey FH; Gerace MR
Acta Psychiatr Scand; 2022 May; 145(5):423-441. PubMed ID: 35178700
[TBL] [Abstract][Full Text] [Related]
52. Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report.
Barros FMR; Tolentino AC; Marques LSK; Schlittler LXC; Oliveira KD; Dalgalarrondo P; Barnes LL; Dos Santos Junior A; Banzato CEM
Schizophr Bull; 2024 Apr; 50(3):717-719. PubMed ID: 38502910
[TBL] [Abstract][Full Text] [Related]
53. Early recognition of clozapine-induced myocarditis.
Annamraju S; Sheitman B; Saik S; Stephenson A
J Clin Psychopharmacol; 2007 Oct; 27(5):479-83. PubMed ID: 17873680
[TBL] [Abstract][Full Text] [Related]
54. There Is Life After the UK Clozapine Central Non-Rechallenge Database.
Oloyede E; Casetta C; Dzahini O; Segev A; Gaughran F; Shergill S; Mijovic A; Helthuis M; Whiskey E; MacCabe JH; Taylor D
Schizophr Bull; 2021 Jul; 47(4):1088-1098. PubMed ID: 33543755
[TBL] [Abstract][Full Text] [Related]
55. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
56. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
[TBL] [Abstract][Full Text] [Related]
57. Clozapine rechallenge after myocarditis.
Reid P; McArthur M; Pridmore S
Aust N Z J Psychiatry; 2001 Apr; 35(2):249. PubMed ID: 11284910
[No Abstract] [Full Text] [Related]
58. Incidence and Management of Clozapine-Induced Myocarditis in a Large Tertiary Hospital.
Higgins JM; San C; Lagnado G; Chua D; Mihic T
Can J Psychiatry; 2019 Aug; 64(8):561-567. PubMed ID: 30599763
[TBL] [Abstract][Full Text] [Related]
59. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.
Reinders J; Parsonage W; Lange D; Potter JM; Plever S
Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025
[TBL] [Abstract][Full Text] [Related]
60. Update on the adverse effects of clozapine: focus on myocarditis.
De Berardis D; Serroni N; Campanella D; Olivieri L; Ferri F; Carano A; Cavuto M; Martinotti G; Cicconetti A; Piersanti M; Saverio Moschetta F; Di Giannantonio M
Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
